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1. Introduction 
The aging process influences cognitive and physical functioning through a variety of 
biological mechanisms.  Multiple facets of cognitive function decline with age, including 
executive function, memory, language, visuomotor coordination, and information 
processing speed.  Strong epidemiological trends show that areas of brain injury due to 
ischemic damage also increase with age.  Areas of ischemic damage known as leukoaraiosis 
appear as hyperintense spots on MRI of the white matter of the brain.  Leukoaraiosis is a 
strong predictor of ischemic stroke and vascular dementia, independent of other known risk 
factors (Markus et al., 2005).  It is also strongly associated with cognitive impairment and 
cognitive decline in individuals who have not yet progressed to dementia (Pantoni et al., 
2007; Schmidt et al., 2007). 
Few studies have examined the genetic contribution to later-age cognitive changes in 
relationship to markers of subclinical ischemic brain injury such as leukoaraiosis.  After 
increasing age, the main risk factors for leukoaraiosis are elevated blood pressure and lack 
of hypertension control (van Dijk et al., 2004). However, there is a significant amount of 
inter-individual variation in leukoaraiosis among subjects with similar duration and 
severity of hypertension (Schmidt et al., 2004; Szolnoki & Melegh, 2006).  Cognitive 
functioning is also highly variable, and it is likely that genetic variability accounts for a 
significant portion of the variation in both structural characteristics of the brain such as 
leukoaraiosis and measures of cognitive function (Deary et al., 2004). 
In this chapter, we present a review of the biological mechanisms that influence 
leukoaraiosis and cognitive function, discuss the public health implications of the clinical 
manifestations of cerebrovascular disease, and explore the broad genetic attributes that 
explain inter-individual variation and covaraition (i.e., pleiotropy) among these brain traits. 
1.1 Biological mechanisms that influence leukoaraiosis and cognitive function 
1.1.1 Physiology and pathology of cerebrovascular disease and leukoaraiosis 
The human brain is composed of gray matter (the cerebral cortex) that is responsible for 
consciousness, movement, and cognition and white matter that consists of nerve fibers that 
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transmit impulses among cerebral areas and to the central nervous system. Leukoaraiosis is 
visible as bright spots in the white matter on T2-weighted MRIs (Markus, 2008; O'Sullivan, 
2008). Leukoaraiosis ranges in severity from small, distinct areas of white matter 
hyperintensity (punctuate lesions) to large regions of white matter hyperintensity (early 
confluent or confluent lesions) (O'Sullivan, 2008). Leukoaraiosis is thought to be a marker of 
cerebral small vessel disease (cerebrovascular disease) in the long, narrow penetrating 
arterioles that supply the white matter with blood (Markus, 2008). This type of small vessel 
disease is defined by areas of diffuse arteriolosclerosis with deposits of a proteinaceous 
substance that includes fibrin, amyloid, and collagen, which results in thickening of the 
vessel and chronic ischemia that leads to demyelination, axonal loss, and gliosis (Markus, 
2008; O'Sullivan, 2008). It occurs in regions of the brain that have low perfusion pressure, 
such as the deep white matter, and results in chronic ischemia and multiple diffuse 
infarctions due to small vessel occlusions (lacunar infarctions), both of which are visible as 
hyperintensity on MRIs (Markus, 2008). In regions of leukoaraiosis, there appears to be 
decreased blood flow (hypoperfusion) and impaired ability to regulate blood flow 
(autoregulation) (Markus, 2008).  
Recently, it has been suggested that endothelial dysfunction, characterized by the inability 
of endothelial cells to perform tasks such as mediation of coagulation, platelet adhesion, and 
immune response, may be the intermediate process between hypertension and the 
alterations in blood flow observed in areas of leukoaraiosis (Hassan et al., 2003; Markus, 
2008). Circulating endothelial markers may show a pro-coagulant pattern of endothelial 
function (e.g. higher circulating levels of thrombomodulin (TM) and lower circulating levels 
of tissue factor pathway inhibitor (TFPI)) that is specific to leukoaraiosis (Hassan et al., 2003) 
and may be related to progression of leukoaraiosis (Markus et al., 2005). Further support for 
endothelial dysfunction comes from the strong association between leukoaraiosis and 
elevated homocysteine level, which is hypothesized to be a mediator of endothelial damage 
(Hassan et al., 2004). 
1.1.2 Hypertension as a predictor of leukoaraiosis 
Development of leukoaraiosis is thought to be a marker of one of the major mechanistic 
pathways between hypertension and clinical endpoints such as ischemic stroke and vascular 
dementia, and is a known risk factor for both of these endpoints (Markus et al., 2005; 
O'Sullivan, 2008). Inadequately controlled hypertension gives rise to ischemic damage of the 
brain that is thought to be the manifestation of underlying cerebrovascular disease (Turner 
& Boerwinkle, 2000). Several studies have also demonstrated an association between 
hypertension in midlife and cognitive decline in later life (Launer et al., 2000), and it has 
been hypothesized that this is due to the cumulative effects of subclinical damage due to 
small vessel disease (Knopman et al., 2001) with leukoaraiosis as a detectable sign of one of 
the main mechanistic pathways implicated (Sierra & Coca, 2006). Hypertension is a leading 
risk factor for ischemic stroke (Roger et al., 2011) and for cognitive decline leading to 
vascular dementia (Launer et al., 2000). Hypertension affects approximately 1 in 3 American 
adults (76.4 million people), and accounts for $43.5 billion in yearly direct and indirect costs 
in the United States (Roger et al., 2011).  
1.1.3 The relationship between leukoaraiosis and cognitive function 
In a review of studies pertaining to leukoaraiosis and cognition, Pantoni et al. (2007) 
conclude that despite different study characteristics, there is almost invariably evidence of 
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an effect of leukoaraiosis on cognition. In particular, leukoaraiosis is more strongly 
associated with decreasing executive function than memory and is also associated with a 
decline in motor performance such as gait disturbances (Pantoni et al., 2007; Schmidt et al., 
2007). The rate of progression of leukoaraiosis over time is also related to cognitive decline, 
and the severity of leukoaraiosis at baseline is a significant predictor of progression 
(Schmidt et al., 2007). It is also important to keep in mind, however, that other factors may 
affect the association between leukoaraiosis and cognitive decline such as brain atrophy and 
stroke (Pantoni et al., 2007; Schmidt et al., 2007). 
1.1.4 Cognitive decline and vascular dementia 
Dementia is a heterogeneous group of disorders with variable etiology that involves 
impairment in cognitive domains such as memory, executive function, and language as well 
as specific physical impairments such as gait abnormalities that cause significant 
impairment in social or occupational function and represent a decline from a previous level 
of functioning (American Psychiatric Association, 2000). The differential diagnosis of 
vascular dementia (VaD), incorporates the underlying vascular cause as well as the 
cognitive and physical symptomology (Pohjasvaara et al., 2000), specifically “focal 
neurological signs and symptoms or laboratory evidence indicative of cerebrovascular 
disease (multiple infarctions involving cortex and underlying white matter) that are judged 
to be etiologically related to the disturbance“ (American Psychiatric Association, 2000). 
Leukoaraiosis and multiple lacunar (small vessel) strokes, both caused by cerebrovascular 
disease, are the primary markers of VaD (Geldmacher & Whitehouse, 1997) and are thought 
to be contributors to cognitive impairment in individuals who have not yet progressed to 
dementia (Pantoni et al., 2007; Schmidt et al., 2007). Several studies have also shown that 
leukoaraiosis is predictive of incident VaD (Prins et al., 2004). 
1.1.5 Complexity in the inter-relationships among clinical outcomes and sub-clinical 
measures 
A complex relationship exists among hypertension, leukoaraiosis, cognitive decline, 
dementia, and stroke. The figure below illustrates what is currently known about the inter-
relationships among these clinical outcomes and subclinical measures, including: 
 Leukoaraiosis is thought to be a manifestation (sub-clinical marker) of cerebrovascular 
disease. 
 Hypertension is a primary risk factor for leukoaraiosis. 
 Leukoaraiosis is a risk factor for cognitive decline and ischemic stroke. 
 Leukoaraiosis, ischemic stroke, and cognitive decline are included in the clinical criteria 
for the diagnosis of vascular dementia. 
 Ischemic stroke (without additional evidence of leukoaraiosis) is a risk factor for 
cognitive decline. 
1.2 Public health implications of the clinical manifestations of cerebrovascular 
disease 
The clinical outcomes that are associated with cerebrovascular disease have large public 
health implications. Ischemic stroke accounts for 87% of all strokes, a leading cause of 
morbidity, mortality, and economic burden in the US (Roger et al., 2011). Stroke is the 
second most common cause of death and disability-adjusted life-years in industrialized 
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countries (Lopez et al., 2001) and the third most common cause of death in the US, 
accounting for approximately 1 in 18 deaths in 2007 (Roger et al., 2011). Over 7 million 
Americans currently living with the cognitive and physical consequences of stroke (Roger et 
al., 2011), and it has been estimated that stroke account for approximately 4% of all direct 
health care costs in the US (Donnan et al., 2008). The risk of first-ever stroke is almost twice 
as high for African Americans as for white Americans, which may in part be due to the 
higher prevalence of hypertension in this group (Roger et al., 2011).  
 
 
Fig. 1. Relationship between subclinical measures and clinical outcomes. Dark blue arrows 
represent risk factor relationships, and dashed blue lines represent clinical criteria. 
Dementia is also an important public health burden in the U.S. and abroad (Haan & 
Wallace, 2004), and the World Health Organization predicts that there will be approximately 
29 million people affected by all forms of dementia by the year 2020 (Essink-Bot et al., 2002). 
Alzheimer’s disease (AD) and other dementias affect over 5.2 million Americans, including 
between 200,000 and 500,000 people under the age of 65. Dementias place a heavy economic 
burden on the health care system, with each Medicare patient with dementia accounting for 
more than three times as much spending than the average beneficiary (Alzheimer’s 
Association, 2008). The aging population of the U.S. is expected to dramatically increase the 
prevalence of dementia, which is thought to affect 3%-11% of people older than 65 and 25%-
47% of people older than 85 (Boustani et al., 2003). Older African Americans are about twice 
as likely to develop AD and other dementias as older white Americans, which may in part 
be due to the higher prevalences of hypertension and diabetes and lower average 
socioeconomic status of this group (Alzheimer’s Association, 2010). 
1.3 Role of genetics in leukoaraiosis and cognitive function 
Genetic factors are likely to account for a significant amount of the inter-individual variation 
in cognitive functioning and brain structure (Deary et al., 2004). Heritability studies, 
candidate gene studies, and genome-wide association studies are beginning to shed light on 
the biological processes involved in the progression from hypertension to the development 
of leukoaraiosis and cognitive decline that are indicators of increased risk of stroke and 
dementia.  
1.3.1 Genetics of leukoaraiosis and cognitive function 
Estimates of heritability for leukoaraiosis range from 0.45-0.71, indicating that genetic 
factors account for a large proportion of the inter-individual variation in this trait (Atwood 
et al., 2004; Carmelli et al., 1998; Turner et al., 2004). Candidate gene studies for 
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leukoaraiosis have primarily concentrated on genes in pathways known to be involved in 
hypertension, vasculature, and endothelial damage. Although initial findings have been 
encouraging, no specific genetic factors have been unequivocally shown to be associated 
with this trait (Paternoster et al., 2009). Genome-wide association studies (GWAS) for this 
trait have also been limited, but are currently being conducted in several ethnic groups. To 
date, the most promising evidence for association is with a region on chromosome 17q25 in 
European Americans (Fornage et al., 2011). 
For cognitive decline, the most promising candidate genes include those that are associated 
with hypertension, leukoaraiosis, Alzheimer’s Disease (AD), normal cognitive functioning, 
cardiovascular function, oxidative stress, and inflammation (Deary et al., 2004), though 
candidate gene studies have not yet established any specific genetic factors that definitively 
affect cognitive decline. GWAS for a variety of cognitive traits are currently underway. 
GWASs that examine the change of cognitive traits over time in multiple cohorts will be 
particularly useful for identifying genetic factors associated with cognitive decline. 
1.3.2 Role of pleiotropy 
Pleiotropy is most simply defined as the condition in which variation in a single gene affects 
multiple traits (Hodgkin, 1998). Defined in this manner, pleiotropic genes range from those 
that encode proteins involved in a single biological pathway that influences multiple disease 
processes and/or organ systems to those that play entirely different roles in multiple biological 
pathways. In some instances, pleiotropy is “the phenomenon in which a single gene controls 
several distinct, seemingly unrelated, phenotypic effects” (Zou et al., 2008). A well-known 
example of pleiotropy in humans is the 4 allele of the apolioprotein E (APOE) gene (Dickstein 
et al., 2010). APOE is a plasma cholesterol transport molecule that resides primarily on very 
low density lipoproteins, and the 4 allele has been shown to be a risk factor for coronary heart 
disease and stroke through mechanisms related directly to lipid transport. However, the 4 
alelle is also a risk factor for AD and cognitive decline, with those carrying the allele having a 
younger age of onset as well as an accelerated pace of cognitive decline. Though the precise 
mechanism by which 4 leads to cognitive decline is not known, the main hypotheses are 
through pathways not directly related or only tangentially related to lipid transport. APOE 
appears to affect brain traits through its role as a chaperone for the amyloid beta protein 
and/or mediation of the phosphorylation of the tau protein.  
The study of pleiotropy in model organisms and humans serves several functions. In model 
organisms, it serves to further the understanding and elucidation of the complex biological 
pathways that regulate the development of traits, providing information about normal 
cellular function, normal development and function at the organismal level, connections 
between previously unrecognized biological processes, and increased predictive ability in 
breeding programs (Hodgkin, 1998). It also it provides insight into the mechanisms of 
evolution, as effects on multiple traits due to a single genetic variant may pose severe 
evolutionary constraints (Cheverud et al., 2004). The findings from pleiotropy studies in 
model organisms, particularly the high degree of connectivity among transcriptional 
modules, have strong implications for understanding the pleiotropic genetic mechanisms 
that are also operating in humans. A greater understanding of the underlying pleiotropic 
mechanisms contributing to human health and disease has the potential to allow for earlier 
identification of individuals at increased risk for disease, the development of more 
efficacious treatments, and the tailoring of particular treatments to people most likely to 
respond positively. 
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1.3.3 Bivariate variance component analysis to assess pleiotropy 
Studies of pleiotropy in humans have generally consisted of bivariate genetic analysis using 
variance decomposition techniques and linkage analysis in biologically related groups of 
traits. Variance decomposition techniques are used to parse the total phenotypic correlation 
in a pair of traits into the correlation due to genetic influences (genetic correlation) and the 
correlation due to environmental influences (environmental correlation) using family 
relationships.  
Bivariate variance decomposition techniques have been used to study pleiotropy in humans 
for a variety of purposes. Comuzzie et al. (1994) estimated the genetic and environmental 
correlations among eight measures of skinfolds in order to inform epidemiologic studies 
that examine these measures as risk factors for heart disease and diabetes. The authors 
argue that studying pleiotropy in risk factors is important because shared genetic or 
environmental effects may confound analyses using these traits if these effects are 
unrecognized. Bivariate genetic analysis is has also been used to identify measureable 
endophenotypes that can be used to study the genetic underpinnings of complex diseases 
with multiple etiologies. For example, Charlesworth et al. (2010) examined the genetic 
correlations between several quantitative characteristics of the eye and primary open-angle 
glaucoma in order to determine the most appropriate endophenotypes to focus on in genetic 
association studies. 
1.4 Motivation for studying pleiotropy of leukoaraiosis and cognitive function 
In this chapter, we focus on estimating the heritabilities, genetic correlations, and 
environmental correlations between leukoaraiosis and seven measures of neurocognitive 
function. In a sample of 759 whites and 720 African Americans, we examine patterns of 
pleiotropy using a bivariate variance components approach. Findings of this work help 
inform the understanding of the genetic relationships among leukoaraiosis and measures of 
cognitive function. A deeper understanding the genetics of leukoaraiosis development and 
its impact on cognitive decline in individuals free of overt neurocognitive disorders may 
help to inform pharmacogenomic drug development and preventive strategies for 
identifying individuals at increased risk of stroke and dementia. Research into the genetic 
architecture of leukoaraiosis and cognitive function in samples that are presymptomatic is 
particularly important because preventive interventions for dementia would need to start 
early, preferably before any brain damage occurs (DeKosky & Marek, 2003). 
2. Methods 
2.1 Sample 
The National Heart, Lung and Blood Institute established the Family Blood Pressure 
Program (FBPP) in 1996 from four existing research networks that were investigating the 
genetics of hypertension and its sequelae (FBPP Investigators, 2002), including The Genetic 
Epidemiology Network of Arteriopathy (GENOA). GENOA recruited hypertensive sibships 
from Rochester, Minnesota and Jackson, Mississippi for linkage and association studies to 
investigate the genetic underpinnings of hypertension and target organ damage related to 
hypertension (Daniels et al., 2004). 
In the initial phase of the GENOA study (Phase I: 1996-2001), all members of sibships 
containing ≥ 2 individuals with essential hypertension clinically diagnosed before age 60 
were invited to participate, including both hypertensive and normotensive siblings (1,583 
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non-Hispanic whites and 1,841 African Americans). The diagnosis of essential hypertension 
was established based on blood pressure levels measured at the study visit (>140 mmHg 
average systolic BP or >90 mmHg average diastolic BP) or a prior diagnosis of hypertension 
and current treatment with antihypertensive medications. Exclusion criteria were secondary 
hypertension, alcoholism or drug abuse, pregnancy, insulin-dependent diabetes mellitus, or 
active malignancy. In the second phase of the GENOA study (Phase II: 2000-2004), 1,241 
white and 1,482 African American participants were successfully re-recruited to measure 
potential target organ damage due to hypertension. Phase I and II GENOA data consist of 
demographic information, medical history, clinical characteristics, lifestyle factors, and 
blood samples for genotyping and biomarker assays. Written informed consent was 
obtained from all subjects and approval was granted by participating institutional review 
boards. All reported phenotype and covariate data used for this analysis was collected 
during the Phase II exam. 
The Genetics of Microangiopathic Brain Injury (GMBI) study (2001-2006) is an ancillary 
study of GENOA undertaken to investigate susceptibility genes for ischemic brain injury. 
Phase II GENOA participants that had a sibling willing and eligible to participate in  
the GMBI study underwent a neurocognitive testing battery to assess several domains  
of cognitive function including learning, memory, attention, concentration, and language. 
Ischemic brain damage to the subcortical and periventricular white matter (leukoaraiosis) 
was quantified by magnetic resonance imaging (MRI) in subjects who had no history  
of stroke or neurological disease and no implanted metal devices. Participants  
were excluded from this analysis if they were less than 45 years of age or had evidence of 
silent stroke (transient ischemic attack) upon examination of their MRI. The analysis 
sample was comprised of 762 whites in 378 sibships and 720 African Americans in  
413 sibships. 
2.2 Leukoaraiosis 
Leukoaraiosis volume (cm3) was obtained via MRI in a separate clinical visit. All MRI scans 
were performed on identically equipped Signa 1.5 T MRI scanners (GE Medical Systems, 
Waukesha, WI, USA) and images were centrally processed at the Mayo Clinic. Symmetric 
head positioning with respect to orthogonal axes was verified by a series of short scout 
scans. Total intracranial volume (head size) was measured from T1-weighted spin echo 
sagittal images, each set consisting of 32 contiguous 5 mm thick slices with no interslice gap, 
field of view = 24 cm, matrix = 256 x 192, obtained with the following sequence: scan  
time = 2.5 min, echo time = 14 ms, repetitions = 2, replication time = 500 ms (Jack et al., 
1989). Total brain and leukoaraiosis volumes were determined from axial fluid-attenuated 
inversion recovery (FLAIR) images, each set consisting of 48 contiguous 3-mm interleaved 
slices with no interslice gap, field of view = 22 cm, matrix = 256 x 160, obtained with the 
following sequence: scan time = 9 min, echo time = 144.8 ms, inversion time = 2,600 ms, 
repetition time = 26,002 ms, bandwidth = +/- 15.6 kHz, one signal average. A FLAIR image 
is a T2-weighted image with the signal of the cerebrospinal fluid nulled, such that brain 
pathology appears as the brightest intracranial tissue. Interactive imaging processing steps 
were performed by a research associate who had no knowledge of the subjects’ personal or 
medical histories or biological relationships. A fully automated algorithm was used to 
segment each slice of the edited multi-slice FLAIR sequence into voxels assigned to one of 
three categories: brain, cerebrospinal fluid, or leukoaraiosis. The mean absolute error of this 
method is 1.4% for brain volume and 6.6% for leukoaraiosis volume, and the mean test-
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retest coefficient of variation is 0.3% for brain volume and 1.4% for leukoaraiosis volume 
(Jack et al., 2001). White matter hyperintensities in the corona-radiata and periventricular 
zone, as well as central gray infarcts (ie, lacunes) were included in the global leukoaraiosis 
measurements. Brain scans with cortical infarctions were excluded from the analyses 
because of the distortion of the leukoaraiosis volume estimates that would be introduced in 
the automated segmentation algorithm. 
2.3 Neuropsychological testing battery 
Neuropsychological tests were conducted in a private room that was free of noise and other 
distractions by trained interviewers. In order to assure accuracy and comparability in test 
administrator performance, a portion (approximately 5%) of all interviews were tape 
recorded and evaluated for accuracy to provide feedback to test administrators. The 
neuropsychological outcome measures used for this analysis are presented in Table 1 along 
with the cognitive functions assessed.  
 
Neurocognitive Test 
Outcome 
Measure 
Cognitive Functions 
Rey’s Auditory Verbal 
Learning Test (RAVLT) 
RAVLT 
delayed recall 
Learning 
Delayed memory 
Vulnerability to interference 
Rey’s Auditory Verbal 
Learning Test (RAVLT) 
RAVLT total 
learning 
Learning 
Immediate memory 
Digit Symbol Substitution 
Test (DSST) 
DSST 
Psychomotor speed 
Visual attention 
Concentration 
Controlled Oral Word 
Association Test (COWA) 
COWA FAS 
Language 
Verbal fluency (phonetic association) 
Controlled Oral Word 
Association Test (COWA) 
COWA 
animals 
Language 
Category fluency (semantic association) 
Stroop Color Word Test 
Stroop color 
word 
Concentration effectiveness 
Ability to shift perceptual sets in 
response to novel stimuli 
Stroop Color Word Test 
Stroop 
interference 
Ability to shift perceptual sets in 
response to novel stimuli 
Table 1. Measures of cognitive function 
2.3.1 Rey’s Auditory Verbal Learning Test (RAVLT) 
Rey’s Auditory Verbal Learning Test (RAVLT) is a brief test that assesses learning and 
memory through multiple learning trials and a 30-minute delayed recall (Rey, 1964). 
Specifically, the measure assesses immediate memory span, new learning, vulnerability to 
interference in learning, and recognition memory. RAVLT testing norms for individuals 
aged 55 and older were developed through Mayo’s Older Americans Normative Studies 
(MOANS), and the testing procedure followed in GMBI was identical to that used in 
MOANS (Ivnik et al., 1992). 
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The examiner begins by reading a list of 15 common words aloud, and participants are 
asked to recall as many of the words as possible in any order. The same procedure is 
repeated four more times using the same list of 15 words. The total number of words that 
the participant remembers correctly over the five trials is recorded and forms the basis of the 
RAVLT total learning outcome measure for this analysis, which assesses immediate 
memory. Delayed recall is assessed by asking the participant to again name as many words 
as he/she remembers after a 30-minute delay, forming the basis of the RAVLT delayed 
learning outcome measure for this analysis. During the 30-minute interim, an interference 
task is performed in which the interviewer reads another set of words aloud, and the 
participant is asked to recall them. Thus, the delayed learning outcome assesses both 
delayed memory as well as vulnerability to interference. 
2.3.2 Wechsler Adult Intelligence Scale Revised (WAIS-R) Digit Symbol  
Substitution Task (DSST) 
The Digit Symbol Substitution task (DSS) from the Wechsler Adult Intelligence Scale 
Revised (WAIS-R) (Wechsler, 1981) is a timed translation test designed to measure complex 
visual attention, sustained and focused concentration, response speed, and visuomotor 
coordination (Lezak, 1995). In this test, participants are given a key in which each number 
corresponds to a special symbol. The task consists of filling in empty boxes below a series of 
random numbers with the symbol corresponding to the appropriate number (translating the 
numbers to symbols). After a practice session to ensure that the participant understands the 
task, participants were given a 90 second time limit to complete as many items as possible. 
The DSST outcome measure for this analysis was the number of correct symbols completed 
in 90 seconds.  
2.3.3 Controlled Oral Word Association Test (COWA) of the Multilingual Aphasia 
Examination 
The Multilingual Aphasia Examination was developed to diagnose the presence of aphasic 
disorders (any type of acquired language impairment), and the Controlled Oral Word 
Association Test (COWA) is a subset of this examination designed to measure verbal fluency 
(Lezak, 1995). Two measures of verbal fluency were used as outcomes for the present study, 
one of letter fluency (Word Fluency Test (WFT)) and one of category fluency (Animal Naming). 
The Word Fluency Test of the COWA assesses letter fluency (phonetic association) by asking 
subjects to generate words orally that begin with a specific letter of the alphabet (“F”, “A”, 
and “S”) for a period of 60 seconds. These letters were chosen because they have been 
demonstrated to allow more vocabulary choices overall than other letters. Scoring of this 
test consisted of adding the total number of admissible words generated for each of the 
three letters. Inadmissable words include proper nouns as well as variations, plurals, and 
repetitions of previously stated words. 
The Animal Naming portion of the COWA assesses category fluency (semantic association) by 
asking subjects to name as many animals as possible in a period of 60 seconds (Lezak, 1995). 
Scoring of this test is the sum of all admissible animals. Inadmissable animals include extinct, 
imaginary, or magical animals, proper names, and variations of previously stated animals. 
2.3.4 Stroop Color Word (CW) Test 
The Stroop Color Word (CW) Test is primarily a measure of concentration effectiveness, 
specifically the ability to shift perceptual sets to correspond with changing demands and the 
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ability to inhibit a customary response to stimulus in favor of a more novel one (Lezak, 1995; 
Stroop, 1935). Administration and scoring of the test to GMBI participants followed 
procedures outlined in the standardized version of the CW test developed by Golden 
(Golden, 1978).  
This test consists of three pages: the word page, the color page, and the color-word page. The 
word page consists of the words “RED”, “GREEN”, and “BLUE” arranged randomly and 
printed in black ink. The color page consists of sets of “XXXX” printed in red, green, or blue 
ink. The color-word page consists of the words from the word page printed in the colors on the 
color page, but no word matches the color in which it is printed (for example, the word “RED” 
is printed in either green or blue ink). For this study, the participant was first asked to read the 
word page as fast as he/she could for 45 seconds, and the total number of correct words was 
recorded. If the participant stated an incorrect word, the interviewer said, “No,” and the 
participant was instructed to read the same word again to correct their error. The same 
procedure was followed for naming the colors on the color page. The participant was then 
asked to state the colors of the words on the color-word page as fast as he/she could in 45 
seconds, and the total number of correctly stated colors were recorded.  
Two measures from this test are used as outcomes in the present study. The color-word 
(CW) score is the total number of correctly stated colors out of 100 from the color-word 
page. The Stroop interference score is the difference in scores between the color page and 
the color-word page.   
2.4 Statistical analysis 
2.4.1 Descriptive statistics 
Data management and statistical analyses were conducted primarily in R version 2.8.0 (R 
Core Development Team, 2008). Distributional plots indicated that the measures of 
leukoaraiosis volume are severely right-skewed, so this variable was transformed by taking 
the natural log of (leukoaraiosis + 1). The cognitive traits appeared to have relatively normal 
distributions; thus, no variable transformations were applied to these variables. T-tests were 
conducted for the outcome measures to test whether there were significant differences in the 
white and African American study participants.  
2.4.2 Covariates 
Biometrical modeling of leukoaraiosis and cognitive function included age at cognitive 
testing, gender, and education as covariates. Relative performance on cognitive tests is 
determined using age- and gender-specific population-based norms, since both of these 
variables are known to affect cognitive function. Age is also a very strong independent 
predictor for leukoaraiosis. Education affects performance on some cognitive tests, as people 
with higher educational attainment tend to perform better (Valenzuela & Sachdev, 2006). 
For this analysis, education was categorized as follows: 0) less than high school, 1) 
completed high school (GED), 2) some college, and 3) completed college (4+ years). To 
account for differences in brain size, intracranial volume was also included in models of 
leukoaraiosis. We conducted multivariable linear mixed models with covariates as predictor 
variables for each outcome measure to explore the relationships between these variables and 
each outcome of interest in GENOA whites and African Americans.  
2.4.3 Biometrical genetic modeling 
The expected covariance of a trait between a pair of individuals can be modeled as a 
function of the variance parameters and the expected correlation between the individuals 
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for genetic effects, based on family relationships (Sing et al., 1987). In this study, SOLAR 
(Sequential Oligogenic Linkage Analysis Routines) (Almasy & Blangero, 1998) was used to 
implement a variance component regression based on maximum likelihood estimation to 
estimate the proportion of phenotypic variance that is due to additive genetic effects, giving 
an estimate of heritability. Shared residual (non-genetic) effects are assumed to be zero 
because the siblings in this study are all adults and have reported living in separate 
households.  
Heritabilities were estimated for the outcome variables (all cognitive traits and 
ln(leukoaraiosis+1)) both with and without covariates (age, sex, education, and TIV) 
included in the biometric models. When covariates are included in the model, the 
heritability estimate is given by [(1-proportion of variance explained by covariates)*h2]*100, 
and represents the hertiability the residual variance of the trait that is not accounted for by 
the covariates. 
The heritability of the traits were tested for significance by comparing the log-likelihood of 
the model in which heritability is estimated to that of the model in which heritability is fixed 
to 0. The null distribution of the likelihood ratio test statistic is a 50:50 mixture of a Chi-
square distribution with one degree of freedom and a point mass at zero.  
2.4.4 Phenotypic, genetic, and environmental correlations 
The phenotypic, genetic, and environmental correlations among all pairs of traits in both 
ethnic groups were estimated in SOLAR, both with and without covariates included in the 
biometric models. The estimated genetic and environmental correlations, ρg and ρe, were 
tested for significance by comparing the log-likelihood of the model in which the parameter 
of interest is estimated to that of the model in which the parameter is fixed to 0.  
The test for pleiotropy, or evidence of shared genetic influences, is as follows: Ho: ρg = 0 vs. 
Ha: ρg  ≠ 0. The null distribution of the likelihood ratio test statistic statistic is a Chi-square 
distribution with one degree of freedom. Rejection of the null hypothesis provides evidence 
of pleiotropy.  
The presence of shared environmental influences (non-genetic influences beyond the 
covariates included in the model) is tested similarly: Ho: ρe = 0 vs. Ha: ρe  ≠ 0. The null 
distribution of the likelihood ratio test statistic statistic is a Chi-square distribution with one 
degree of freedom. Rejection of the null hypothesis provides evidence that there are shared 
environmental influences on the traits. 
3. Results 
3.1 Descriptive statistics 
Descriptive statistics of the outcome measures and covariates for the 762 white and 720 
African American participants, as well as T-tests comparing the samples, are presented in 
Tables 2 and 3. GENOA whites are 58.1% female, have a mean age at the time of cognitive 
testing of 61.3 years (range= 45-84 years), and have a mean leukoaraiosis volume of 8.11cm3 
(range=1.2-62 cm3). GENOA African Americans have a much larger percentage of females 
(72.6%), have a higher mean age of cognitive testing (63.3 years, range = 45-91 years)), and 
have a higher mean volume of leukoaraiosis with greater variability (9.56cm3, range=2.0-126 
cm3). Approximately half of both whites and African Americans attended at least some 
college; however, only 5.2% of white participants did not graduate from high school or 
obtain a GED while this was true for 28.3% of African American participants. The mean 
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values for all outcome measures were significantly different in whites and African 
Americans except for Stroop interference. Leukoaraiosis was strongly right skewed in both 
populations, but had a relatively normal distribution after taking the natural logarithm.  
 
  
Whites 
 
African Americans 
 
Trait Category N Percentage N Percentage 
Education 0 (Less than HS) 40 5.2% 204 28.3% 
 1 (HS/GED) 329 43.2% 205 28.5% 
 2 (Some College) 246 32.3% 127 17.6% 
 3 (Grad/Professional) 147 19.3% 184 25.6% 
Gender Male 319 41.9% 197 27.4% 
 Female 443 58.1% 523 72.6% 
Table 2. Descriptive characteristics of the samples 
 
 Whites African Americans  
Trait  N  Mean (±SD) N  
Mean 
(±SD) 
T-test  
P-valuea 
Leukoaraiosis volume, cm3 714 8.11 (6.83) 574 9.56 (9.89) 0.0028 
Ln (leukoaraiosis+1) 714 2.06 (0.05) 574 2.16 (0.55) 0.0002 
RAVLT delayed recall  758  9.08 (3.27) 708 6.80 (3.36) <2.2E-16 
RAVLT total learning  759  47.7 (9.8)  712 40.1 (9.4) <2.2E-16 
DSST  758  50.2 (12.4)  697 32.9 (13.6) <2.2E-16 
COWA FAS 760  32.4  (13.6) 687 28.6 (11.7) 1.96E-08 
COWA animals 762  19.3  (4.9) 716 14.9 (4.5) <2.2E-16 
Stroop color word 740  34.5 (9.3)  648 22.3 (10.1) <2.2E-16 
Stroop interference 740  32.8 (9.3)  648 33.6 (11.8) 0.4450 
a T-test p-value for a test of equality of trait means in whites and African Americans.  
Table 3. Comparison of outcome measures  
3.2 Associations between covariates and outcome measures 
In order to explore the relationship between covariates and each outcome of interest, we 
conducted multivariable linear mixed models with covariates as predictor variables for each 
outcome measure. In both whites and African Americans, age, gender, and education were 
significant predictors for all cognitive measures except that education was not a significant 
predictor of Stroop interference in whites and gender was not a significant predictor of 
Stroop color word in African Americans after accounting for the other covariates. As 
expected, increasing age was associated with lower cognitive scores, while increasing 
education was associated with higher cognitive scores. Female gender also showed a trend 
of being associated with higher cognitive scores. In both groups, increasing age and total 
intracranial volume were associated with increasing leukoaraiosis volume, while gender 
and education were not associated with this measure.  
The amount of variance explained by the covariates, as measured by R2, showed a consistent 
pattern between the two groups. R2 was lowest for Stroop interference (0.018 in whites and 
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0.074 in African Americans) and highest for DSST (0.411 in whites and 0.529 in African 
Americans). The amount of variance explained by covariates in the remainder of the 
cognitive measures ranged from 0.122 to 0.309 in whites and from 0.207 to 0.294 in African 
Americans. Variance of ln(leukoaraiosis+1) explained by covariates was higher in whites 
(0.309) than in African Americans (0.213). 
3.3 Genetic variance (heritability) 
In order to examine the contribution of genetic factors to the observed variation in the traits, 
we used a biometrical approach to estimate the proportion of variance in the traits explained 
by genetic factors (heritabilities) both with and without inclusion of covariates in the models 
(Table 4). Heritabilities of all traits were highly significant in both whites and African 
Americans (p-value<0.001) with the exception of Stroop interference in African Americans 
that showed only a marginally significant heritability, illustrating that all of the traits under 
study are influenced by genetic factors. Similar patterns of heritability were observed 
between the two groups, though African Americans tended to have lower heritabilities than 
whites for most traits. 
 
Trait 
h2 for Trait 
Modeled 
without 
Covariates 
h2 for Trait 
Modeled 
with 
Covariates 
Proportion 
of Variance 
Explained 
by 
Covariates 
Percent Variation 
Due to Genetic 
Factors After 
Accounting for 
Covariatesa 
Whites     
Ln(leukoaraiosis+1) 0.656*** 0.529*** 0.311 36.45 
RAVLT delayed recall  0.602*** 0.526*** 0.222 40.92 
RAVLT total learning  0.627*** 0.516*** 0.308 35.71 
DSST  0.774*** 0.843*** 0.403 50.33 
COWA FAS 0.441*** 0.366*** 0.139 31.51 
COWA animals 0.503*** 0.349*** 0.152 29.60 
Stroop color word 0.586*** 0.429*** 0.276 31.06 
Stroop interference 0.302*** 0.275*** 0.023 26.87 
 
African Americans     
Ln(leukoaraiosis+1) 0.485*** 0.432*** 0.217 33.83 
RAVLT delayed recall  0.494*** 0.390*** 0.203 31.08 
RAVLT total learning  0.560*** 0.440*** 0.279 31.72 
DSST  0.810*** 0.556*** 0.525 26.41 
COWA FAS 0.710*** 0.536*** 0.300 37.52 
COWA animals 0.551*** 0.329*** 0.260 24.35 
Stroop color word 0.532*** 0.440*** 0.232 33.79 
Stroop interference 0.135*** 0.154* 0.075 14.25 
a [(1 – Proportion of variance explained by adjustment covariates)*h2]*100 
For all traits modeled with covariates, biometric models included age, sex, and education. The biometric 
model for ln(leukoaraiosis+1) also included TIV. 
Null hypothesis of tests: h2 = 0 
* 0.01 < p-value < 0.05,  ** 0.001 < p-value < 0.01,  *** p-value < 0.001 
Table 4. Trait heritabilities 
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Heritabilities in traits modeled without covariates were lowest for Stroop interference (0.302 
in whites, 0.135 in African Americans) and highest for DSST (0.774 in whites, 0.81 in African 
Americans), with the majority of heritabilities in the range of 0.45 to 0.6. Leukoaraiosis had a 
higher heritability in whites (0.656) than in African Americans (0.485). After including 
covariates in the biometric models, heritabilities for the traits were generally lower but 
remained highly significant. Again, Stroop interference had the lowest heritability in both 
groups (0.275 in whites, 0.154 in African Americans) and DSST had the highest (0.843 in 
whites, 0.556 in African Americans), with the remaining traits ranging between 0.33 and 
0.54. Leukoaraiosis still showed higher heritability in whites (0.529) than in African 
Americans (0.432).  
The proportion of the observed trait variance accounted for by covariates estimated with 
biometric modeling mirrored the relationships we observed in multivariate linear mixed 
modeling, described above. The lowest proportion of variance explained was for Stroop 
interference (0.023 in whites, 0.075 in African Americans) and the highest was for DSST 
(0.403 in whites, 0.525 in African Americans). For the remainder of the traits, the proportion 
of variance explained by covariates ranged from 0.139 (COWA FAS) to 0.311 (leukoaraiosis) 
in whites and from 0.203 (RAVLT delayed recall) to 0.3 (COWA FAS) in African Americans.  
In order to determine the proportion of variation in the traits explained by genetic factors, 
we multiplied the proportion of variation not explained by the covariates by the heritability. 
Expressed as a percentage of total variation, genetic factors explain the lowest amount of 
variation in Stroop interference in both groups (26.87% in whites, 14.25% in African 
Americans). The largest amount of variation explained by genetic factors in whites was for 
DSST (50.33%) followed by RAVLT delayed recall (40.92%) and leukoaraiosis (36.45%).  
In African Americans, genetic factors explained the largest percentage of variation in 
COWA FAS (37.52%) followed by leukoaraiosis (33.83%) and Stroop color word (33.79%). 
For the majority of traits, the amount of variation explained by genetic factors was lower in 
African Americans than in whites, but most traits in both groups had at least 25% of 
variation explained by genetic factors, showing that genetics has an important influence on 
these traits.   
3.4 Phenotypic correlations between trait pairs 
The patterns observed in the correlations estimated biometrically in SOLAR are presented in 
Table 5. The strongest correlation in the traits modeled with covariates was between the two 
RAVLT measures (0.755 in whites, 0.729 in African Americans), and the weakest correlations 
were between leukoaraiosis and all cognitive traits (ranging from -0.001 to -0.083). In general, 
multiple measures from the same test exhibited stronger correlations than measures across 
tests, which is intuitive since measures from the same test are assessing different but closely 
related cognitive functions. Patterns of correlation in whites and African Americans were very 
similar, though whites generally tended to exhibit somewhat stronger correlations. 
3.5 Genetic and environmental correlations between trait pairs 
In order to begin to understand the extent to which pleiotropic genetic effects may be 
contributing to each pair of traits, we used a biometrical approach to estimate genetic and 
environmental correlations (Table 6). Overall, there were far more significant genetic 
correlations (pleiotropic effects) between trait pairs than environmental correlations, 
indicating that shared genetic effects were more common in these pairs of traits than shared  
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Leuko 
RAV-
DR 
RAV-
TL DSST C-FAS C-AN 
Str-
CW 
Str- 
Int 
Whites         
Leuko 0.529***  -0.253 -0.295 -0.294 -0.072 -0.174 -0.232 -0.110 
RAV-DR -0.083 0.526*** 0.816 0.442 0.274 0.373 0.376 0.052 
RAV-TL -0.063 0.755 0.516***  0.523 0.346 0.429 0.441 0.147 
DSST -0.064 0.213 0.269 0.843***  0.376 0.334 0.600 0.268 
C-FAS -0.023 0.163 0.234 0.265 0.366***  0.440 0.345 0.160 
C-AN -0.039 0.261 0.311 0.175 0.367 0.349***  0.309 0.134 
Str-CW 0.003 0.186 0.226 0.424 0.262 0.160 0.429***  -0.134 
Str-Int -0.071 -0.010 0.089 0.228 0.128 0.107 -0.233 0.275***  
 
African Americans 
Leuko 0.432***  -2.10 -0.281 -0.270 -0.213 -0.172 -0.197 -0.108 
RAV-DR -0.007 0.390***  0.790 0.416 0.307 0.285 0.275 0.153 
RAV-TL -0.079 0.729 0.440***  0.492 0.401 0.358 0.308 0.257 
DSST -0.075 0.188 0.220 0.556***  0.557 0.489 0.534 0.311 
C-FAS -0.081 0.136 0.020 0.298 0.536***  0.540 0.347 0.311 
C-AN -0.031 0.143 0.188 0.245 0.395 0.329***  0.357 0.204 
Str-CW -0.056 0.145 0.132 0.332 0.170 0.161 0.440***  -0.189 
Str-Int -0.021 0.046 0.139 0.194 0.219 0.129 -0.339 0.154*  
Leuko = Ln(leukoaraios+1), RAV-DR = RAVLT delayed recall, RAV-TL = RAVLT total learning, C-FAS 
= COWA FAS, C-AN = COWA animals, Str-CW = Stroop color word, Str-Int = Stroop interference 
Above diagonal: phenotypic correlations, p, for traits modeled without covariates 
Below diagonal: phenotypic correlations, p, for traits modeled with covariates 
Diagonal: heritabilities from polygenic analysis, h2, for traits modeled with covariates 
For all traits modeled with covariates, biometric models included age, sex, and education. The biometric 
model for ln(leukoaraiosis+1) also included TIV. 
Null hypothesis of tests: h2 = 0 (diagonal) 
* 0.01 < p-value < 0.05, ** 0.001  < p-value < 0.01,  *** p-value < 0.001 
Table 5. Biometrically derived phenotypic correlations among traits 
environmental effects. For all estimates of genetic and environmental correlations, 
adjustment covariates were included in the biometric models. 
The majority of significant genetic correlations observed were in whites. In whites, 
significant genetic correlations ranged from 0.263 (RAVLT total learning and DSST) to 0.918 
(RAVLT total learning and RAVLT delayed recall). Other highly significant genetic 
correlations (p-value<0.001) were between DSST and Stroop color word (0.7) and between 
RAVLT total learning and COWA animals (0.55). Many of the pairs involving RAVLT, 
COWA, and DSST also showed significant genetic correlations, ranging from 0.263 to 0.476. 
Leukoaraiosis and RAVLT had a marginally significant negative genetic correlation (-0.28), 
indicating that genes shared between these two traits have opposite effects on the traits (for 
example, a certain genetic variation may increase leukoaraiosis volume while decreasing 
learning scores). No other evidence of pleiotropic effects was found between leukoaraiosis 
and cognitive measures.  
In contrast to the relative abundance of genetic correlations between these measures, there 
were very few significant environmental correlations in whites. The most significant 
www.intechopen.com
 
Brain Injury – Pathogenesis, Monitoring, Recovery and Management 
 
54
environmental correlation was between the trait pair that also had the highest genetic 
correlation, RAVLT total learning and RAVLT delayed recall (0.586), although the 
environmental correlation was substantially less than the genetic correlation. This indicates 
that for this trait pair, shared genetic effects have a stronger influence than shared 
environmental effects, though both contribute to the observed strong phenotypic 
correlation. The only other highly significant environmental correlation was between Stroop 
color word and Stroop interference (-0.427). This correlation is negative since poor cognitive 
performance is indicated by a low score on Stroop color word but by a high score on Stroop 
interference. Only two other trait pairs exhibited even marginally significant environmental 
correlations in whites. Leukoaraiosis had a negative environmental correlation with Stroop 
interference (-0.274) and the two measures from the COWA had a positive environmental 
correlation (0.293).   
 
 
Leuko 
RAV-
DR 
RAV-
TL DSST C-FAS C-AN 
Str-
CW 
Str- 
Int 
Whites         
Leuko 0.529*** 0.078 0.178 -0.008 -0.092 -0.136 -0.066 -0.274* 
RAV-DR -0.233 0.526*** 0.586*** -0.015 -0.072 0.185 0.087 -0.024 
RAV-TL -0.280* 0.918*** 0.516*** 0.354 0.149 0.142 0.128 0.092 
DSST -0.092 0.329** 0.263* 0.843*** 0.107 0.015 0.021 0.276 
C-FAS 0.062 0.476** 0.350* 0.418** 0.366*** 0.293* 0.163 0.185 
C-AN 0.084 0.372* 0.550** 0.310* 0.495* 0.349*** 0.023 0.157 
Str-CW 0.078 0.296 0.336* 0.700*** 0.413* 0.371* 0.429*** -0.427*** 
Str-Int 0.230 0.010 0.091 0.280 0.007 -0.004 0.146 0.275*** 
 
African Americans 
Leuko 0.432*** -0.161 -0.261 -0.232 -0.169 -0.127 -0.194 0.130 
RAV-DR 0.215 0.390*** 0.596*** 0.327* 0.167 0.166 0.040 0.035 
RAV-TL 0.158 0.915*** 0.440*** 0.401** 0.322* 0.128 0.017 0.035 
DSST 0.078 0.036 0.045 0.556*** 0.442** 0.270* -0.005 0.237 
C-FAS 0.010 0.102 0.075 0.179 0.536*** 0.313* -0.019 0.113 
C-AN 0.124 0.101 0.286 0.228 0.533** 0.329*** 0.158 0.020 
Str-CW 0.128 0.293 0.278 0.698*** 0.363* 0.167 0.440*** -0.541*** 
Str-Int -0.422 0.010 0.432 0.164 0.507 0.522 0.099 0.154* 
Leuko = Ln(leukoaraios+1), RAV-DR = RAVLT delayed recall, RAV-TL = RAVLT total learning, C-FAS 
= COWA FAS, C-AN = COWA animals, Str-CW = Stroop color word, Str-Int = Stroop interference 
Above diagonal: environmental correlations, e 
Below diagonal: genetic correlations, g 
Diagonal: heritabilities from univariate polygenic analysis, h2, for adjusted traits 
For all adjusted traits, biometric models included age, sex, and education. The biometric model for 
ln(leukoaraiosis+1) also included TIV. 
Null hypothesis of tests: e = 0 (above diagonal) 
Null hypothesis of tests: g = 0 (below diagonal) 
Null hypothesis of tests: h2 = 0 (diagonal) 
* 0.01 < p-value < 0.05,  ** 0.001 < p-value < 0.01,  *** p-value < 0.001 
Table 6. Genetic and enviromental correlations among traits 
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The overall patterns of genetic and environmental correlations in African Americans were 
strikingly similar to the patterns observed in whites. However, many of the genetic 
correlations in African Americans did not reach statistical significance due to larger standard 
errors in their estimates, and there was slightly more evidence of shared environmental effects. 
Two of the four highly significant genetic correlations observed in whites were also observed 
in African Americans. RAVLT total learning and RAVLT delayed recall were the most 
strongly genetically correlated (0.915) followed by DSST and Stroop color word (0.698). The 
only other significant genetic correlations were between the two measures of COWA (0.533) 
and between COWA FAS and Stroop color word (0.363). There were no significant genetic 
correlations between leukoaraiosis and any of the cognitive traits. 
As with whites, the most highly significant environmental correlation was between the two 
measures of RAVLT (0.596) and between Stroop color word and Stroop interference (-0.541). 
The direction and magnitudes of the correlations for these traits were also the same in 
African Americans as they were in whites. The other strongly significant environmental 
correlations observed in African Americans were between DSST and RAVLT total learning 
(0.401) and DSST and COWA FAS (0.442). Four additional pairs of traits also exhibited 
marginally significant environmental correlations, including the two COWA measures 
(0.313) that also showed a marginally significant environmental correlation in whites.  
4. Discussion 
4.1 Heritability of leukoaraiosis 
In our study, the heritability of leukoaraiosis was 0.529 in whites and 0.432 in African 
Americans, after adjustment for age, sex, and total intracranial volume. This finding is 
consistent with heritability estimates from comparable studies.  Heritability was estimated 
to be 0.71 in study of white male twins (mean age 73 years) after adjustment for age and 
head size (Carmelli et al., 1998) and 0.55 in a sample of stroke- and dementia-free subjects 
(mean age 61.0 years) after adjustment for sex, age, age2, and total cranial volume (Atwood 
et el., 2004). Turner et al. (2004) showed that leukoaraiosis has a consistently high 
heritability even after adjustment for blood pressure. These high heritabilities imply that 
much of the inter-individual differences in variation of leukoaraiosis are due to differences 
in genetics. 
4.2 Heritability of cognitive function  
Our study estimates that the majority of heritabilities of seven measures of cognitive 
function in whites and African Americans are between ~0.35 and ~0.55. Previous studies of 
the heritability of cognitive functioning has been conducted primarily in twin studies that 
use factor analysis to identify a common factor to act as a proxy for overall cognitive 
function, and the findings point to a higher heritability for this measure than was estimated 
in our study. For example, McGue and Christensen (2002) estimated the heritability of 
general cognitive function as measured by five cognitive tasks comprised of fluency, digit 
span, and recall to be 0.70. Finkel et al. (1995) peformed quantitative genetic analysis on four 
measures of cognitive function (verbal, spatial, perceptual speed, and memory) and showed 
that heritability for a general cognitive factor was between 0.54 and 0.81 in two samples 
across several age groups of adults (from young to elderly). 
Our results show that there are differences in heritability across cognitive measures, with 
processing speed having the highest heritability in whites (0.843) and African Americans 
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(0.556). Other studies have also shown that processing speed has the strongest genetic 
influence among measures of executive function (Carmelli et al., 2002). The heritability of 
executive function generally tends to be higher than that of memory, with heritabilities for 
executive functions between 0.34-0.70 (Carmelli et al., 2002; Sleegers et al., 2007) and 
heritabilities for memory function closer to 0.2-0.4 (McGue & Christensen, 2001; Plomin et 
al., 1994; Sleegers et al., 2007). In GENOA whites, memory measures (RAVLT) had slightly 
higher heritabilities than most of the executive function tests except for DSST. However, in 
African Americans, heritability of memory measures tended to be similar to those of 
executive funtion.  
While existing research supports true differences in the heritabilities of cognitive domains, a 
portion of the observed differences may be due to the nature of the tests and scoring 
procedures. More complex tests such as Stroop may be more susceptible to measurement 
error than less complex tests such as DSST, and test scores that are mathematically 
manipulated (e.g., Stroop interference) are particularly susceptible to this type of error. 
Increased measurement error may lead to lower heritability estimations as well as weaker 
genetic and environmental correlations among trait pairs. 
4.3 Bivariate variance component analysis in leukoaraiosis and cognitive traits  
We found that in GENOA whites, measures of cognitive function exhibit substantial 
evidence of genetic correlation (pleiotropy), with measures of similar tests showing stronger 
genetic correlation. Evidence of phenotypic correlation due to shared environment was 
largely limited to a smaller number of cognitive trait pairs in African Americans. However, 
we detected no evidence of genetic or environmental correlations between measures of 
cognitive function and leukoaraiosis.  
The lack of evidence of genetic correlation between leukoaraiosis and cognitive function 
in this study stands in contrast to a study conducted by Carmelli, et al. (2002), which used 
maximum likelihood nested modeling techniques to estimate the proportion of variance 
in leukoaraiosis and executive control function due to genetic, shared environmental, and 
non-shared environmental effects in 142 pairs of elderly twins (mean age = 73 years). The 
total phenotypic correlation between leukoaraiosis and executive function was -0.20, and 
they found that 70% of the total phenotypic correlation was accounted for by shared genes 
while 30% was accounted for by shared environments. While this is substantial, the 
contribution of overlapping genes (genes shared between the executive control factor and 
leukoaraiosis) to the genetic variance in executive function was only 8% due to the 
relatively low phenotypic correlation. The lack of detecting shared genetic or 
enviornmental effects between leukoaraiosis and measures of cognitive function in the 
GENOA study was partially due to the very low phenotypic correlations among 
leukoaraiosis and the measures of cognitive function, which may be a function of the 
younger average age of GENOA participants. 
Other studies of the shared genetic components of cognitive traits tend to focus on change in 
cognition over time. Variance components analysis of the relationship between cognitive 
change and perception speed in a study of 292 twins aged 40-84 revealed that 90% of the 
age-related variance and 70% of the genetic variance in cognitive function was shared with 
perception speed, demonstrating that there is a genetic component to processing speed 
which also influences general cognitive functioning (Finkel & Pedersen, 2000). This finding 
was supported by the GENOA study, as processing speed (DSST) exhibited genetic 
correlation with nearly all of the other cognitive measures in whites. Although GENOA 
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African Americans showed little evidence for genetic correlation among cognitive traits, a 
significant genetic correlation was found for DSST and Stroop color word. 
4.4 Differences in the genetic parameters for whites and African Americans 
Heritabilities of leukoaraiosis and cognitive measures showed a consistent pattern in whites 
and African Americans. DSST had the highest heritability (0.883 in whites, 0.556 in African 
Americans), Stroop interference had the lowest heritability (0.275 in whites, 0.154 in African 
Americans), and leukoaraiosis and the other cognitive measures had mid-range heritabilities 
(0.35-0.53 in whites, 0.33-0.54 in African Americans). However, heritabilities showed a clear 
trend of being lower in African Americans, with COWA FAS being the only notable 
exception (heritability = 0.366 in whites, 0.536 in African Americans). A similar trend was 
observed for overall phenotypic correlations and genetic correlations, with African 
Americans showing a similar but weaker correlational structure. 
There are several reasons that could account for the lower observed heritabilities in African 
Americans. Since heritability is the fraction of the total variability of the trait accounted for 
by additive genetic factors, lower heritabilities could result from greater trait variation (a 
larger denominator) or from a smaller contribution from additive genetic effects (a smaller 
numerator). Differences in either the numerator or the demoninator could be due to true 
population differences between whites and African Americans, or they could simply be 
artefacts of the GENOA samples, such as differences in age or family structure. We 
examined the possibility that age or family structure may be responsible for the differences 
in heritability by re-estimating heritabilities in sub-samples of each ethnic group that were 
of equivalent age or had equivalent family compositions (data not shown). Trends in the 
heritabilities remained consistent across sub-samples, so we concluded that the lower 
heritabilities observed in the African American GENOA sample reflect a true difference in 
the population parameters of the groups studied and is not an artefact of the GENOA 
sample structure. However, it is possible that the same factors hypothesized to contribute to 
variability in test scores among ethnic groups (e.g., cultural variability in familiarity with 
testing response sets, motivation and attitudes toward test-taking) may have increased the 
measurement error of the cognitive function tests in the African American sample, resulting 
in lower heritability estimates for this group. 
Lower heritabilities of leukoaraiosis and the seven cognitive traits as well as differences in 
the genetic and environmental correlations between GENOA whites and African Americans 
suggest that non-genetic factors have a greater effect in African Americans than in whites 
for all of the brain traits studied. Though similar patterns were observed in whites and 
African Americans, genetic correlations (evidence of shared genetic effects) among cognitive 
traits tended to be higher and more significant in whites. While very little evidence of 
environmental correlation (shared environmental effects) between cognitive traits was 
observed in whites, eight of the 21 pairs of cognitive traits (38%) had evidence of significant 
environmental correlation in African Americans. Therefore, it is likely that non-genetic 
factors are indeed playing a larger role in affecting variation in brain traits in African 
American GENOA sample. 
4.5 The effect of age on genetic parameter estimation 
Most studies of the genetic and environmental factors associated with leukoaraiosis have 
had samples composed of individuals who have already experienced clinical endpoints such 
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as stroke or severe cognitive decline. The relatively young age range of our sample provided 
the unique opportunity to examine the relationships between leukoaraiosis and cognitive 
phenotypes in asymptomatic individuals, at a time when preventive treatment would be 
most effective. However, the young age of our sample also imposed constraints, including 
the limited variability in the leukoaraiosis phenotype. In addition, it has been shown that 
heritabilities of cognitive traits tend to vary with age (Knopman et al., 2001; Mattay, 2008). 
Since this study was cross-sectional, we did not have the ability to examine how 
heritabilities and genetic correlations change over time. Differential heritabilities across age 
groups also implies that there may be genetic factors that show age-related changes in 
penetrance with respect to cognitive traits. It is therefore plausible that the genetic 
correlations between leukoaraiosis and cognitive traits may also change with age. 
5. Conclusion  
The complex relationship between subclinical measures and clinical outcomes underscores 
the importance of studying leukoaraiosis and cognitive decline as the predecessors of stroke 
and dementia in order to better elucide the shared and unique contributions of genetic 
factors to the disease pathologies that result from hypertension and other risk factors. This 
study illustrates that the genetic and environmental influences on the subclinical measures 
of stroke and dementia vary substantially between measures of structural injury 
(leukoaraiosis) and performance on cognitive tests, and that unique patterns of genetic and 
environmental correlation exist across cognitive domains (memory vs. executive function).  
All of the traits studied demonstrate significant heritability, indicating that genetic factors 
account for a substantial portion of the variability in leukoaraiosis as well as multiple 
measures of cognitive function. Some of the cognitive measures, particularly those that 
assessed similar cognitive domains, demonstrated a significant degree of shared genetic 
effects, while others demonstrated a greater degree of shared environmental effects. 
Leukoaraiosis, while heritable, does not share any genetic or environmental influences with 
the cognitive measures. Patterning of heritability and genetic/environmental correlations 
showed definitive trends that were consistent across ethic groups, but one clear difference 
was that cognitive measures tended to have more shared genetic effects in whites and more 
shared enviornmental effects in African Americans. These results indicate that the 
environmental and genetic factors that predispose individuals to leukoaraiosis and 
cognitive decline are likely to be best understood and studied at the family and community 
levels. Integrating genetic information with family history and cultural or socio-economic 
stressors and supports is likely to contribute to new knowledge of the unique and shared 
risk factors for these traits, and thus lead to more effective preventive strategies. 
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